Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sen. Hatch on retail prices

Executive Summary

Utah Republican issues Aug. 10 statement retracting an earlier criticism of "excessive" retail markups. During the March Senate debate on Sen. Pryor's (D-Ark.) S 2000 ("The Pink Sheet" March 16, p. 3), "I inadvertently made a one-sentence statement that implied that one of the causes of drug price increases was excessive markup at the retail and wholesale level," Hatch explains. "In the heat of a spirited debate, I misspoke." Hatch adds: "I understand the increasing pressures on drug wholesaler and retailers as they strive to remain successful in today's often difficult economic environment."
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS021381

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel